Kimball Electronics, Inc. (KE) Stock Analysis

Kimball Electronics generated 46% of fiscal 2026 net sales from automotive customers, 29% from medical, and 25% from industrial, and its three largest customers -- Nexteer Automotive (18%), Philips (11%), and ZF (11%) -- together accounted for approximately 40% of net sales. The company operates 11 manufacturing facilities across the U.S., Mexico, China, India, the Netherlands, Poland, Romania, and Thailand, deriving a substantial majority of revenue from operations outside the United States. Kimball completed its largest-ever acquisition, Helvoet Polymer Technologies, on July 1, 2026, expanding its precision molded plastics and medical device manufacturing capabilities and adding facilities in India and the Netherlands.

Kimball earns revenue as a contract manufacturer, producing printed circuit board assemblies, higher-level and final assemblies, medical disposables, drug delivery devices, and precision molded plastics to customer specifications under agreements that typically lack firm long-term production commitments -- customers generally do not commit to firm production schedules beyond one quarter, and margins on new program start-ups are typically diluted early before recovering as programs mature. Raw materials, particularly semiconductors, are sourced globally and have experienced periodic shortages and allocations; many customer contracts allow periodic price re-pricing tied to component costs, though Kimball can bear the risk of cost increases between repricing windows. During fiscal 2026, tariffs implemented under various U.S. trade authorities increased supply-chain costs, most of which the company recovered through contractual pass-through and repricing mechanisms. Kimball funded a portion of the Helvoet acquisition price through its credit facilities, and integrating Helvoet's India and EU operations, employees, and customer relationships is a key execution risk going forward.